Subacute administration of human umbilical cord-derived mesenchymal stem cells is associated with neurobehavioral improvement, myeloid immune modulation, and altered HMGB1 dynamics after experimental ischemic stroke
Subacute administration of human umbilical cord-derived mesenchymal stem cells is associated with neurobehavioral improvement, myeloid immune modulation, and altered HMGB1 dynamics after experimental ischemic stroke. // Brain Research. – URL: https://www.sciencedirect.com/science/article/pii/S0006899326004798?dgcid=rss_sd_all
Subacute administration of human umbilical cord-derived mesenchymal stem cells is associated with neurobehavioral improvement, myeloid immune modulation, and altered HMGB1 dynamics after experimental ischemic stroke. Brain Research. https://www.sciencedirect.com/science/article/pii/S0006899326004798?dgcid=rss_sd_all
“Subacute administration of human umbilical cord-derived mesenchymal stem cells is associated with neurobehavioral improvement, myeloid immune modulation, and altered HMGB1 dynamics after experimental ischemic stroke.” Brain Research.
@article{article8238,
title = {Subacute administration of human umbilical cord-derived mesenchymal stem cells is associated with neurobehavioral improvement, myeloid immune modulation, and altered HMGB1 dynamics after experimental ischemic stroke},
journal = {Brain Research},
url = {https://www.sciencedirect.com/science/article/pii/S0006899326004798?dgcid=rss_sd_all}
}